Perran Fulden Yumuk Selected Research

Perran Fulden Yumuk Research Topics

Disease

12	Neoplasms (Cancer) 07/2022 - 01/2004
9	Breast Neoplasms (Breast Cancer) 07/2022 - 06/2011
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 05/2010
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 03/2005
2	Adenocarcinoma 05/2022 - 12/2020
2	Stomach Neoplasms (Stomach Cancer) 05/2022 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2021
2	Disease Progression 01/2020 - 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2022
1	Residual Neoplasm 05/2022
1	Lymphatic Metastasis 01/2022
1	Thrombocytopenia (Thrombopenia) 07/2021
1	Anaplastic Thyroid Carcinoma 01/2021
1	Epithelioid Hemangioendothelioma 10/2020
1	Inflammation (Inflammations) 09/2020
1	Insulin Resistance 09/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2020
1	Ductal Carcinoma 09/2020
1	Drug-Related Side Effects and Adverse Reactions 04/2020
1	Circulating Neoplastic Cells 01/2020
1	Pain (Aches) 01/2020
1	Anorexia 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Glioma (Gliomas) 01/2020
1	Fatigue 01/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Pathologic Complete Response 01/2019
1	Chordoma 08/2018
1	Gingival Hyperplasia 06/2016
1	Malignant Mesothelioma 02/2016
1	Weight Gain 06/2011

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	AlbuminsIBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 12/2020 - 04/2020
2	AfatinibIBA 04/2022 - 12/2020
2	Tyrosine Kinase InhibitorsIBA 04/2022 - 01/2022
2	B7-H1 AntigenIBA 01/2021 - 08/2020
2	ErbB Receptors (EGF Receptor)IBA 12/2020 - 01/2020
2	Hormones (Hormone)IBA 09/2020 - 01/2020
1	atezolizumabIBA 12/2022
1	beta-Aminoethyl Isothiourea (AET)IBA 07/2022
1	osimertinibIBA 06/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	human ERBB2 proteinIBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	alectinibIBA 01/2022
1	Ado-Trastuzumab EmtansineIBA 07/2021
1	TransferasesIBA 07/2021
1	pembrolizumabIBA 01/2021
1	trametinibIBA 01/2021
1	dabrafenibIBA 01/2021
1	IpilimumabIBA 01/2021
1	AntibodiesIBA 10/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020
1	Blood Glucose (Blood Sugar)IBA 09/2020
1	Epidermal Growth Factor (EGF)IBA 09/2020
1	Glucose (Dextrose)FDA LinkGeneric 09/2020
1	Insulin (Novolin)FDA Link 09/2020
1	Anaplastic Lymphoma KinaseIBA 06/2020
1	CrizotinibIBA 06/2020
1	C-Reactive ProteinIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	regorafenibIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 07/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	VemurafenibIBA 06/2016
1	taxaneIBA 06/2011
1	AnthracyclinesIBA 06/2011
1	Docetaxel (Taxotere)FDA Link 05/2010
1	Cisplatin (Platino)FDA LinkGeneric 05/2010

Therapy/Procedure

9	Therapeutics 07/2022 - 06/2011
8	Drug Therapy (Chemotherapy) 12/2022 - 05/2010
5	Neoadjuvant Therapy 05/2022 - 01/2019
2	Adjuvant Chemotherapy 06/2011 - 03/2005
1	Gastrectomy 01/2021
1	Chemoradiotherapy 12/2020
1	Palliative Care (Palliative Therapy) 11/2020
1	Molecular Targeted Therapy 08/2018
1	Pneumonectomy (Lung Volume Reduction) 02/2016
1	Orchiectomy (Orchidectomy) 01/2004
1	Ovariectomy (Oophorectomy) 01/2004
1	Mastectomy (Mammectomy) 01/2004
1	Prostatectomy (Retropubic Prostatectomy) 01/2004